Tumour vascular targeting
Top Cited Papers
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (6) , 436-446
- https://doi.org/10.1038/nrc1627
Abstract
Proteins that are expressed on the tumour vasculature but not on the vasculature of normal tissues can be used for imaging and targeting purposes. Vascular targets include proteins expressed on the endothelial cell, such as DELTA4 or ROBO4, as well as those that are secreted into the stroma around the vessels, such as the differentially spliced isoforms of fibronectin and tenascin. Ligands for the vascular targets include antibodies and possibly certain aptamers, such as modified DNA. Delivery of a suitable bioactive molecule (toxin, cytokine, etc.) coupled to a targeting ligand can be used to eradicate solid tumours. In the longer term, it is possible that vascular targets could be used to develop a cancer vaccine.Keywords
This publication has 129 references indexed in Scilit:
- Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endotheliumFEBS Letters, 2005
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 CProtein Engineering, Design and Selection, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Tumor‐targeting properties of antibody–vascular endothelial growth factor fusion proteinsInternational Journal of Cancer, 2002
- Human Endomucin Is an Endothelial MarkerBiochemical and Biophysical Research Communications, 2001
- Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglinEuropean Journal Of Cancer, 2000
- Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant AntibodyThe American Journal of Pathology, 1999
- 131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II StudyActa Oncologica, 1999
- Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1992